The Veo Insulin Pump and CGM System is the world's only insulin pump engineered with a Low Glucose Suspend (LGS) function. LGS is designed to help prevent severe hypoglycemia day and night.
Take Advantage of the Evidence.
CGM can help you:
- Tailor your insulin delivery based on your meals, exercise and activity.
- Anticipate your glucose trends and minimize lows and highs (1,2)
- Reduce A1C levels compared to multiple daily injections or insulin pump technology alone (3-6)
- Detect nighttime hypoglycemia and respond accordingly (7)
More and more insurance companies are covering the cost of CGM. If you haven't recently checked your insurance plan, it might be worth checking your coverage.
Find out if you have coverage
- Keenan B, Cartaya R, and Mastrototaro J. Accuracy of a New Real-Time Continuous Glucose Monitoring Algorithm. J Diabetes Sci Technol. 2010;4(1):111-118.
- Mastrototaro J, Shin J, Marcus A, et al. The Accuracy and Efficacy of Real-Time Continuous Glucose Monitoring Sensor in Patients with Type 1 Diabetes. J Diabetes Sci Technol. 2007;1(3):400-404.
- Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Continuous glucose monitoring and intensive treatment of Type 1 diabetes. N Engl J Med. 2008;359:1464-1476.
- Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. The Effects of Continuous Glucose Monitoring in Well-Controlled Type 1 Diabetes. Diabetes Care. 2009;32:1378-1383.
- Bergenstal RM, Tamborlane WV, Ahmann A, et al. Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med. 2010;363(4):311-320.
- Slover RH, Welsh JB, Creigo A, et al. Effectiveness of sensor-augmented pump therapy in children and adolescents with type 1 diabetes in the STAR 3 study. Pediatr Diabetes. 2011 Jul 3 [Epub ahead of print].
- Ahmet A, Dagenais S, Barrowman NJ, et al. Prevalence of Nocturnal Hypoglycemia in Pediatric Type 1 Diabetes: A Pilot Study Using Continuous Glucose Monitoring. J Pediatr. 2011;159:297-302.